CD8A and neoplasm: Pharmacologic blockade of VEGF-A induced a marked increase in the influx of tumor-rejecting CD8+ T cells over Tregs that was dependent on attenuation of FAS antigen ligand expression and led to CD8-dependent tumor growth suppression (73).